SHC - Rasio utang marang kapitalisasi buku Nordion

Logo grafis Sotera Health Company (SHC)

Adhering to ESG standards, Sotera Health Company (SHC) invests significant funds in treatment systems to neutralize hazardous chemicals. Michael Petras Jr.'s strategic course is based on optimizing internal processes and expanding production resources. This price chart, where the indicator stands at 3.49, confirms the status of a global leader in sterilization and laboratory research, guaranteeing the maximum safety of medical products.

Sotera Health Company - Utang-utang marang kapitalisasi buku SHC (periode 04.07.2022 - 28.10.2026)

Sotera Health Corp (SHC) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:
Rega saham Sotera Health Company|SHC - Prakiraan konsensus analis
- data kapitalisasi pasar:
Nilai pasar Nordion|SHC - Nilai Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Sotera Health|SHC - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku soterahealth.com|SHC - Aset Agregat Perusahaan
- data utang lan likuiditas:
Rasio Total Utang marang Ekuitas Sotera Health Company|SHC - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Sterigenics|SHC - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku Nordion|SHC - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Sotera Health
Analisis fundamental perusahaan:Sotera Health Company
Barang unggulan Sterigenics

This indicator reflects the total liabilities-to-equity ratio, measuring the business's reliance on debt financing and the risks of potential default. Analyzing the trajectory of the financial leverage of Sotera Health Company (SHC) confirms the company's high resilience, as the non-cyclical nature of sterilization services guarantees a stable cash flow for debt service regardless of macroeconomic fluctuations.

Karo sapa Sotera Health Company saingan

Utang-utang marang kapitalisasi buku A (Agilent Technologies)|questdiagnostics.com - Utang-utang marang kapitalisasi buku|Illumina (ILMN) - Rasio utang marang kapitalisasi buku|EXAS - Rasio utang marang nilai buku|RVTY: Utang-utang marang kapitalisasi buku|BIO (Bio-Rad Corp) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku Anbio Biotechnology|Rasio utang marang kapitalisasi buku quidel.com (QDEL)|OPKO Health - Utang marang nilai buku|Utang-utang marang nilai buku CDNA (CareDx, Inc)|Rasio utang marang kapitalisasi buku MRVI|Utang-utang marang aset resik Fulgent FLGT|Utang-utang marang kapitalisasi buku LAB (Standard BioTools Inc.)|CTKB: Utang-utang marang aset resik|OraSure - Rasio utang marang kapitalisasi buku|XGN (Exagen) - Utang-utang marang aset resik|MDXH: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik LUCD|Prenetics Global - Rasio utang marang kapitalisasi buku|Utang-utang marang nilai buku imdxinc.com IMDX|Utang marang nilai buku Trinity Biotech (TRIB)|Utang marang modal buku ProPhase Labs Inc PRPH|AIMD (Ainos Corp) - Utang-utang marang kapitalisasi buku|CODX: Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Heart Test Laboratories HSCS|biomerica.com (BMRA) - Rasio utang marang aset resik|CDIO (Cardio Diagnostics Holdings Inc.) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku Virax Biolabs Group Limited (VRAX)|Bluejay (BJDX) - Utang marang nilai buku|Rasio utang marang aset resik Aspira Women's Health Inc (AWH)|Utang-utang marang kapitalisasi buku Accelerate Diagnostics|Rasio utang marang aset resik centogene.com CNTG|ENZ (Enzo) - Utang-utang marang kapitalisasi buku|FRES - Utang-utang marang nilai buku|GENE: Utang-utang marang kapitalisasi buku|ME (23andMe Inc) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku Psychemedics